{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:21:51Z","timestamp":1791408111481,"version":"4.3.3"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012154","name":"Graduate Research and Innovation Projects of Jiangsu Province","doi-asserted-by":"publisher","award":["SJCX24_0728"],"award-info":[{"award-number":["SJCX24_0728"]}],"id":[{"id":"10.13039\/501100012154","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["8247267 0"],"award-info":[{"award-number":["8247267 0"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82573133"],"award-info":[{"award-number":["82573133"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82403427"],"award-info":[{"award-number":["82403427"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2023M741795"],"award-info":[{"award-number":["2023M741795"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002949","name":"Government of Jiangsu Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002949","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017962","name":"Jiangsu Commission of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017962","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.canlet.2025.218125","type":"journal-article","created":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T16:11:34Z","timestamp":1762618294000},"page":"218125","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Radiation-induced glioblastoma stem cell-mediated T cell exhaustion via EGR1-Gal3-LAG3 axis in glioblastoma"],"prefix":"10.1016","volume":"636","author":[{"given":"Hui","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenhua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiankun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junlei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiting","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaoyuan","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kefan","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuxing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junxia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danling","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7338-7416","authenticated-orcid":false,"given":"Junfei","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2025.218125_bib1","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1001\/jama.2023.0023","article-title":"Glioblastoma and other primary brain malignancies in adults: a review","volume":"329","author":"Schaff","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.canlet.2025.218125_bib2","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/s41590-019-0433-y","article-title":"Mechanisms of immunotherapy resistance: lessons from glioblastoma","volume":"20","author":"Jackson","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.canlet.2025.218125_bib3","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41571-020-00447-z","article-title":"EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood","volume":"18","author":"Weller","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.canlet.2025.218125_bib4","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","article-title":"Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial","volume":"10","author":"Stupp","year":"2009","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.canlet.2025.218125_bib5","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2025.218125_bib6","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1093\/neuonc\/noac169","article-title":"Quantitative proteomic landscapes of primary and recurrent glioblastoma reveal a protumorigeneic role for FBXO2-dependent glioma-microenvironment interactions","volume":"25","author":"Buehler","year":"2023","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.canlet.2025.218125_bib7","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1101\/gad.261982.115","article-title":"Cancer stem cells in glioblastoma","volume":"29","author":"Lathia","year":"2015","journal-title":"Genes Dev."},{"key":"10.1016\/j.canlet.2025.218125_bib8","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.drup.2018.03.003","article-title":"Glioblastoma cancer stem cell biology: potential theranostic targets","volume":"42","author":"Sharifzad","year":"2019","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.canlet.2025.218125_bib9","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/nrneurol.2010.67","article-title":"Neuro-oncology: unmasking the multiforme in glioblastoma","volume":"6","author":"Goodwin","year":"2010","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.canlet.2025.218125_bib10","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/nature05236","article-title":"Glioma stem cells promote radioresistance by preferential activation of the DNA damage response","volume":"444","author":"Bao","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2025.218125_bib11","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/nature11287","article-title":"A restricted cell population propagates glioblastoma growth after chemotherapy","volume":"488","author":"Chen","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2025.218125_bib12","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.stem.2018.12.009","article-title":"The architects of the tumor ecosystem","volume":"24","author":"Prager","year":"2019","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.canlet.2025.218125_bib13","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13045-024-01544-7","article-title":"Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives","volume":"17","author":"Lin","year":"2024","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.canlet.2025.218125_bib14","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41392-025-02299-4","article-title":"Glioblastoma at the crossroads: current understanding and future therapeutic horizons","volume":"10","author":"Singh","year":"2025","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.canlet.2025.218125_bib15","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1007\/s10555-022-10051-5","article-title":"The multifaceted mechanisms of malignant glioblastoma progression and clinical implications","volume":"41","author":"Sun","year":"2022","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.canlet.2025.218125_bib16","doi-asserted-by":"crossref","DOI":"10.1126\/science.abe6474","article-title":"Pan-cancer single-cell landscape of tumor-infiltrating T cells","volume":"374","author":"Zheng","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.canlet.2025.218125_bib17","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1146\/annurev-immunol-110519-071134","article-title":"Insights gained from single-cell analysis of immune cells in the tumor microenvironment","volume":"39","author":"Ren","year":"2021","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.canlet.2025.218125_bib18","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1158\/0008-5472.CAN-24-2760","article-title":"Tumor-immune cell interactions in cancer progression","volume":"85","author":"Zhou","year":"2025","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2025.218125_bib19","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/clc.4960100807","article-title":"Correlation of the size of isolated right ventricular infarction with the changes of ST segment in dogs","volume":"10","author":"Aramaki","year":"1987","journal-title":"Clin. Cardiol."},{"key":"10.1016\/j.canlet.2025.218125_bib20","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/s41577-019-0221-9","article-title":"Defining 'T cell exhaustion'","volume":"19","author":"Blank","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.canlet.2025.218125_bib21","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/j.ccell.2023.07.011","article-title":"Neoadjuvant immune checkpoint blockade: a window of opportunity to advance cancer immunotherapy","volume":"41","author":"Topalian","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2025.218125_bib22","doi-asserted-by":"crossref","DOI":"10.1172\/JCI163447","article-title":"Immune checkpoint blockade in glioblastoma: from tumor heterogeneity to personalized treatment","volume":"133","author":"Arrieta","year":"2023","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.canlet.2025.218125_bib23","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/s41571-018-0003-5","article-title":"Current state of immunotherapy for glioblastoma","volume":"15","author":"Lim","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.canlet.2025.218125_bib24","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2019-000379","article-title":"T lymphocyte-targeted immune checkpoint modulation in glioma","volume":"8","author":"Kelly","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.canlet.2025.218125_bib25","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ccell.2017.02.009","article-title":"The microenvironmental landscape of brain tumors","volume":"31","author":"Quail","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2025.218125_bib26","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.52176","article-title":"Understanding the glioblastoma immune microenvironment as basis for the development of new immunotherapeutic strategies","volume":"9","author":"Pombo Antunes","year":"2020","journal-title":"eLife"},{"key":"10.1016\/j.canlet.2025.218125_bib27","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/s41568-021-00397-3","article-title":"Glial and myeloid heterogeneity in the brain tumour microenvironment","volume":"21","author":"Andersen","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2025.218125_bib28","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s13045-023-01499-1","article-title":"Targeting LAG-3, TIM-3, and TIGIT for cancer immunotherapy","volume":"16","author":"Cai","year":"2023","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.canlet.2025.218125_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104207","article-title":"Pan-cancer landscape of T-cell exhaustion heterogeneity within the tumor microenvironment revealed a progressive roadmap of hierarchical dysfunction associated with prognosis and therapeutic efficacy","volume":"83","author":"Zhang","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.canlet.2025.218125_bib30","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nn.4537","article-title":"Purine synthesis promotes maintenance of brain tumor initiating cells in glioma","volume":"20","author":"Wang","year":"2017","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.canlet.2025.218125_bib31","doi-asserted-by":"crossref","first-page":"4947","DOI":"10.1158\/0008-5472.CAN-17-0114","article-title":"MYC-regulated mevalonate metabolism maintains brain tumor-initiating cells","volume":"77","author":"Wang","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2025.218125_bib32","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aau4972","article-title":"Targeting pyrimidine synthesis accentuates molecular therapy response in glioblastoma stem cells","volume":"11","author":"Wang","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.canlet.2025.218125_bib33","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1158\/2159-8290.CD-20-0331","article-title":"The RNA m6A reader YTHDF2 maintains oncogene expression and is a targetable dependency in glioblastoma stem cells","volume":"11","author":"Dixit","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2025.218125_bib34","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ccell.2024.12.006","article-title":"Infiltrating plasma cells maintain glioblastoma stem cells through IgG-Tumor binding","volume":"43","author":"Gao","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2025.218125_bib35","doi-asserted-by":"crossref","first-page":"4795","DOI":"10.1038\/s41467-022-32311-2","article-title":"Circular EZH2-encoded EZH2-92aa mediates immune evasion in glioblastoma via inhibition of surface NKG2D ligands","volume":"13","author":"Zhong","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2025.218125_bib36","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/s41392-023-01471-y","article-title":"T cells in health and disease","volume":"8","author":"Sun","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.canlet.2025.218125_bib37","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.immuni.2016.05.001","article-title":"Lag-3, Tim-3, and TIGIT: Co-inhibitory receptors with specialized functions in immune regulation","volume":"44","author":"Anderson","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2025.218125_bib38","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1016\/j.devcel.2022.05.007","article-title":"PDGF signaling inhibits mitophagy in glioblastoma stem cells through N(6)-methyladenosine","volume":"57","author":"Lv","year":"2022","journal-title":"Dev. Cell"},{"key":"10.1016\/j.canlet.2025.218125_bib39","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1158\/1535-7163.MCT-15-0600","article-title":"A novel small-molecule compound that potently inhibits growth of colorectal cancer","volume":"15","author":"Ruiz de Sabando","year":"2016","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.canlet.2025.218125_bib40","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s13195-022-01050-3","article-title":"Kruppel-like factor 5 accelerates the pathogenesis of Alzheimer's disease via BACE1-mediated APP processing","volume":"14","author":"Wang","year":"2022","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.canlet.2025.218125_bib41","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1056\/NEJMoa2109970","article-title":"Relatlimab and Nivolumab versus Nivolumab in untreated advanced melanoma","volume":"386","author":"Tawbi","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2025.218125_bib42","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1101\/gad.324301.119","article-title":"Glioblastoma stem cells: lessons from the tumor hierarchy in a lethal cancer","volume":"33","author":"Gimple","year":"2019","journal-title":"Genes Dev."},{"key":"10.1016\/j.canlet.2025.218125_bib43","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.stem.2019.03.006","article-title":"Single-cell transcriptomics uncovers glial progenitor diversity and cell fate determinants during development and gliomagenesis","volume":"24","author":"Weng","year":"2019","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.canlet.2025.218125_bib44","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.stem.2016.12.001","article-title":"Glioblastoma cancer stem cells evade innate immune suppression of self-renewal through reduced TLR4 expression","volume":"20","author":"Alvarado","year":"2017","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.canlet.2025.218125_bib45","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1158\/2159-8290.CD-20-1848","article-title":"Transcription elongation machinery is a druggable dependency and potentiates immunotherapy in glioblastoma stem cells","volume":"12","author":"Qiu","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2025.218125_bib46","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/s41586-023-06061-0","article-title":"Lysine catabolism reprograms tumour immunity through histone crotonylation","volume":"617","author":"Yuan","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2025.218125_bib47","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-008880","article-title":"Oncolytic herpes simplex virus expressing IL-2 controls glioblastoma growth and improves survival","volume":"12","author":"Bommareddy","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.canlet.2025.218125_bib48","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1158\/0008-5472.CAN-17-2433","article-title":"Activation of the receptor tyrosine kinase AXL regulates the immune microenvironment in glioblastoma","volume":"78","author":"Sadahiro","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2025.218125_bib49","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1200\/JCO.2016.66.6552","article-title":"Immune checkpoint inhibition for hypermutant glioblastoma multiforme resulting from germline Biallelic mismatch repair deficiency","volume":"34","author":"Bouffet","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2025.218125_bib50","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1158\/2159-8290.CD-16-0575","article-title":"Immunogenomics of hypermutated glioblastoma: a patient with germline POLE deficiency treated with checkpoint blockade immunotherapy","volume":"6","author":"Johanns","year":"2016","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2025.218125_bib51","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1001\/jamaoncol.2020.1024","article-title":"Effect of Nivolumab vs Bevacizumab in patients with recurrent glioblastoma: the CheckMate 143 phase 3 randomized clinical trial","volume":"6","author":"Reardon","year":"2020","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.canlet.2025.218125_bib52","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22105282","article-title":"Understanding LAG-3 signaling","volume":"22","author":"Chocarro","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2025.218125_bib53","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/s41590-022-01210-5","article-title":"Autoreactive CD8(+) T cells are restrained by an exhaustion-like program that is maintained by LAG3","volume":"23","author":"Grebinoski","year":"2022","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.canlet.2025.218125_bib54","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.tips.2025.06.010","article-title":"TREM2 and LAG-3 in cancer and Alzheimer's disease immunotherapy","volume":"46","author":"Yuan","year":"2025","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.canlet.2025.218125_bib55","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.tips.2025.05.008","article-title":"Exploring new frontiers in LAG-3 biology and therapeutics","volume":"46","author":"Wang","year":"2025","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.canlet.2025.218125_bib56","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1186\/s12935-023-03157-5","article-title":"Prognostic significance of Lymphocyte-activation gene 3 (LAG3) in patients with solid tumors: a systematic review, meta-analysis and pan-cancer analysis","volume":"23","author":"Li","year":"2023","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.canlet.2025.218125_bib57","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1200\/JCO.23.02172","article-title":"Phase I study of fianlimab, a human lymphocyte activation Gene-3 (LAG-3) monoclonal antibody, in combination with cemiplimab in advanced melanoma","volume":"42","author":"Hamid","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2025.218125_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2022.100639","article-title":"A first-in-human study of the anti-LAG-3 antibody favezelimab plus pembrolizumab in previously treated, advanced microsatellite stable colorectal cancer","volume":"7","author":"Garralda","year":"2022","journal-title":"ESMO Open"},{"key":"10.1016\/j.canlet.2025.218125_bib59","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-011652","article-title":"Therapeutic potential of targeting LAG-3 in cancer","volume":"13","author":"Davar","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.canlet.2025.218125_bib60","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3858\/emm.2012.44.6.044","article-title":"Galectin-3 increases the motility of mouse melanoma cells by regulating matrix metalloproteinase-1 expression","volume":"44","author":"Wang","year":"2012","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.canlet.2025.218125_bib61","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1093\/neuonc\/noac250","article-title":"RAGE ablation attenuates glioma progression and enhances tumor immune responses by suppressing galectin-3 expression","volume":"25","author":"Zhang","year":"2023","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.canlet.2025.218125_bib62","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1434467","article-title":"The role of Galectin-3 in modulating tumor growth and immunosuppression within the tumor microenvironment","volume":"7","author":"Farhad","year":"2018","journal-title":"OncoImmunology"},{"key":"10.1016\/j.canlet.2025.218125_bib63","doi-asserted-by":"crossref","DOI":"10.1172\/JCI147552","article-title":"Chitinase-3-like 1 protein complexes modulate macrophage-mediated immune suppression in glioblastoma","volume":"131","author":"Chen","year":"2021","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.canlet.2025.218125_bib64","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1038\/s41467-024-47959-1","article-title":"Galectin-3 impairs calcium transients and beta-cell function","volume":"15","author":"Jiang","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2025.218125_bib65","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s00262-017-1995-x","article-title":"IDO and galectin-3 hamper the ex vivo generation of clinical grade tumor-specific T cells for adoptive cell therapy in metastatic melanoma","volume":"66","author":"Melief","year":"2017","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.canlet.2025.218125_bib66","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.1158\/0008-5472.CAN-23-0783","article-title":"Galectin-3 cooperates with CD47 to suppress phagocytosis and T-cell immunity in gastric cancer peritoneal metastases","volume":"83","author":"Fan","year":"2023","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2025.218125_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.plipres.2019.101010","article-title":"Galectin-3 modulation of T-cell activation: mechanisms of membrane remodelling","volume":"76","author":"Gilson","year":"2019","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.canlet.2025.218125_bib68","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/s41419-022-04773-1","article-title":"KLF5 inhibition overcomes oxaliplatin resistance in patient-derived colorectal cancer organoids by restoring apoptotic response","volume":"13","author":"Shen","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2025.218125_bib69","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1158\/1535-7163.MCT-18-1366","article-title":"The novel small-molecule SR18662 efficiently inhibits the growth of colorectal cancer in vitro and in vivo","volume":"18","author":"Kim","year":"2019","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.canlet.2025.218125_bib70","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/s41571-023-00782-x","article-title":"Emerging evidence for adapting radiotherapy to immunotherapy","volume":"20","author":"Galluzzi","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383525006974?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383525006974?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T23:49:01Z","timestamp":1785973741000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383525006974"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":70,"alternative-id":["S0304383525006974"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2025.218125","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiation-induced glioblastoma stem cell-mediated T cell exhaustion via EGR1-Gal3-LAG3 axis in glioblastoma","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2025.218125","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"218125"}}